Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-03-01

Clinical Trial Update: Dexmedetomidine Infusion Effect on Hemodynamic Variables During Craniotomy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating dexmedetomidine infusion effects on hemodynamic variables during craniotomy, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Ain Shams University | Conditions: Hemodynamic Instability, Supratentorial Neoplasms | Phase 4 | Status: COMPLETED